Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of HSA-free Varilrix in Toddlers
NCT02570126Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2015
- Primary completion
- Oct 2016
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of varicella virus vaccine live in varicella (VZV) (2 arms), sponsored by GSK. Primary endpoint: Number of Subjects Reporting Fever. Started Nov 2015; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT02570126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570126.